Discovery of ETS1 as a New Gene Predisposing to Dilated Cardiomyopathy
Open Access
- 13 August 2025
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 15 (16) , 2031
Abstract
Background/Objectives: Dilated cardiomyopathy (DCM), defined as dilation and contractile dysfunction of the left or both cardiac ventricles, remains the most common category of primary myocardial disease worldwide. It is the most prevalent cause of chronic heart failure and the most common indication for cardiac transplantation in young subjects. Accumulating evidence increasingly highlights the substantial genetic defects underlying DCM. Nevertheless, the genetic ingredients accountable for DCM in a major percentage of patients remain indefinite. Methods: A multigenerational pedigree suffering from DCM and a total of 276 healthy volunteers employed as controls were recruited from the Chinese Han-ethnicity population. A whole-exome sequencing (WES) assay followed by a Sanger sequencing analysis of the genomic DNAs from the available family members was implemented. Functional characterization of the identified genetic variant was completed by dual-luciferase analysis. Results: A new heterozygous variation in the ETS1 (erythroblast transformation-specific 1) gene, NM_005238.4:c.447T>G;p.(Tyr149*), was identified by WES and validated by Sanger sequencing analysis to co-segregate with DCM in the whole DCM family. This nonsense ETS1 variant was not found in 276 control subjects. Functional examination elucidated that Tyr149*-mutant ETS1 lost the ability to transactivate its downstream target genes CLDN5 (claudin 5) and ALK1 (activin receptor-like kinase 1), two genes crucial for cardiovascular embryonic development and postnatal structural remodeling. Conclusions: The present investigation reveals ETS1 as a new gene predisposed to human DCM and indicates ETS1 haploinsufficiency as an alternative molecular pathogenesis underlying DCM, providing a potential molecular target for genetic counseling and early diagnosis as well as personalized prophylaxis of DCM.Keywords
All Related Versions
Funding Information
- The Natural Science Foundation of Minhang District, Shanghai, China (2024MHZ015)
This publication has 124 references indexed in Scilit:
- Ets1 is required for proper migration and differentiation of the cardiac neural crestDevelopment, 2010
- Claudin-5 as a Novel Estrogen Target in Vascular EndotheliumArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Deletion of ETS-1, a gene in the Jacobsen syndrome critical region, causes ventricular septal defects and abnormal ventricular morphology in miceHuman Molecular Genetics, 2009
- Fast and accurate short read alignment with Burrows–Wheeler transformBioinformatics, 2009
- Claudin-5 levels are reduced in human end-stage cardiomyopathyJournal of Molecular and Cellular Cardiology, 2008
- Claudin-5 localizes to the lateral membranes of cardiomyocytes and is altered in utrophin/dystrophin-deficient cardiomyopathic miceJournal of Molecular and Cellular Cardiology, 2005
- The 11q terminal deletion disorder: A prospective study of 110 casesAmerican Journal of Medical Genetics Part A, 2004
- Ets-1 expression is associated with cranial neural crest migration and vasculogenesis in the chick embryoGene Expression Patterns, 2003
- Ets-1 and Ets-2 Transcription Factors Are Essential for Normal Coronary and Myocardial Development in Chicken EmbryosCirculation Research, 2003
- Ets-1 is involved in transcriptional regulation of the chick inducible nitric oxide synthase gene in embryonic ventricular myoctyesMolecular and Cellular Biochemistry, 2001